An amazing turning point! Thank you for wording it this way.
I can see that there may be another period of consolidation and support until the next milestone / announcement, but today represents the start of recurring revenue and real value to those who have waited for years for this life changing treatment.
More details coming surely, on the uptake amongst the rett population, and nz 2591 too.
i dont see any reason to "dump" or sell. If anything, long term holders might choose to manage risk due to their (now) large NEU holdings, which they have every right to do and may even feel some hesitation in doing so...
- Forums
- ASX - By Stock
- NEU
- Ann: DAYBUE (trofinetide) launched in US - Neuren earns US$40m
NEU
neuren pharmaceuticals limited
Add to My Watchlist
10.1%
!
$13.81

Ann: DAYBUE (trofinetide) launched in US - Neuren earns US$40m, page-22
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.81 |
Change
1.270(10.1%) |
Mkt cap ! $1.729B |
Open | High | Low | Value | Volume |
$12.96 | $14.00 | $12.91 | $12.76M | 929.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 743 | $13.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.81 | 285 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 253 | 13.820 |
3 | 716 | 13.810 |
2 | 416 | 13.800 |
5 | 1309 | 13.790 |
4 | 1316 | 13.780 |
Price($) | Vol. | No. |
---|---|---|
13.830 | 1 | 1 |
13.840 | 788 | 10 |
13.850 | 1423 | 4 |
13.860 | 1392 | 6 |
13.870 | 1291 | 4 |
Last trade - 14.28pm 26/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online